Echo Therapeutics (ECTE) Reports Q3 Loss of $0.04
Tweet
Share
E-mailGet Alerts ECTE Hot Sheet
Join SI Premium – FREE
Echo Therapeutics (NASDAQ: ECTE) reported Q3 EPS of ($0.04), versus ($0.02) reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
- KinderCare Learning Companies, Inc. (KLC) Misses Q2 EPS by 2c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
